Related Experiment Video
Updated: Aug 13, 2025

Laryngeal Mask Airway LMA Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway SGA
Published on: July 14, 2023
Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income
Jefferson Antonio Buendía1, Ricardo Hernández-Sarmiento2, Jorge Enrique Rojas Medina3
1Research group in Pharmacology and Toxicology "INFARTO," Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia; Department of Pediatrics and Intensive Care, Fundación Cardioinfantil-Instituto de Cardiología, Universidad de la Sabana, Bogotá, Colombia.
Insights
Continuous positive airway pressure (CPAP) is not cost-effective for preterm infants with respiratory distress in Colombia. Further research is needed to confirm these findings on CPAP
Area of Science:
- Neonatal Medicine
- Health Economics
- Clinical Research
Background:
- Continuous positive airway pressure (CPAP) is increasingly used for respiratory distress in preterm infants.
- Uncertainty exists regarding the cost-effectiveness of CPAP compared to standard care.
- This study evaluates the economic value of CPAP in this population.
Purpose of the Study:
- To assess the cost-utility of CPAP versus supplemental oxygen (SO) in spontaneously breathing preterm infants with respiratory distress.
- To determine if the clinical benefits of CPAP justify its additional costs.
- To inform healthcare decision-making regarding CPAP implementation.
Main Methods:
- A decision tree model was employed to estimate costs and quality-adjusted life-years (QALYs).
- Probabilistic analysis and value of information analysis were conducted.
- Cost-effectiveness was evaluated against a willingness-to-pay threshold of US$5180.
Main Results:
- CPAP incurred an incremental cost of US$600 and provided an incremental benefit of 0.04 QALY compared to SO.
- The estimated incremental cost per QALY was US$13,172.
- The incremental net monetary benefit was negative (US$-324), indicating CPAP was not cost-effective.
Conclusions:
- CPAP is not a cost-effective intervention for preterm infants with respiratory distress in Colombia when compared to SO.
- Further real-world effectiveness data and economic evaluations in diverse settings are recommended.
- The findings suggest a need for continued evidence generation to guide CPAP use in neonatal care.
Objectives:
Despite the increased popularity of continuous positive airway pressure (CPAP) for preterm infants with respiratory distress, there is still uncertainty about whether the additional costs of this device justify the clinical benefits provided. This study aims to evaluate the cost-utility of CPAP in spontaneously breathing preterm infants with respiratory distress.
Methods:
Using a decision tree model, we estimated the cost and quality-adjusted life-years (QALYs) associated with CPAP and supplemental oxygen alone by headbox or low-flow nasal cannula (SO). The model was analyzed probabilistically, and a value of information analysis was conducted to inform the value of conducting further research to reduce current uncertainties in the evidence base. Cost-effectiveness was evaluated at a willingness-to-pay value of US$5180.
Results:
The mean incremental cost of CPAP versus SO was US$600. The mean incremental benefit of CPAP versus SO was 0.04 QALY. The expected incremental cost per QALY was estimated at US$13 172. The mean incremental net monetary benefit was US$-324 with a 95% credible interval of US$-536 to US$-201. The overall expected value of perfect information per person affected by the decision was estimated to be US$2346.
Conclusions:
Compared with SO, the use of CPAP in spontaneously breathing preterm infants with respiratory distress is not cost-effective in Colombia. Evidence should continue to be generated with real-life effectiveness data and economic evaluations in other countries to confirm our findings.
More Related Videos
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Mechanical Ventilation I: Indication and Settings
Cardiopulmonary Resuscitation II: ACLS Airway Management
Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

